Kampers J, Orjuela-Grimm M, Schober T, Schulz TF, Stiefel M, Klein C, Körholz D, Mauz-Körholz C, Kreipe H, Beier R, et al. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules. Leuk Lymphoma. 2016:1-6.
Chou H, Zhu Y, Ma Y, Berkowitz GA. The CLAVATA signaling pathway mediating stem cell fate in shoot meristems requires Ca(2+) as a secondary cytosolic messenger. Plant J. 2016.
Liu Z, Yang N, Lv Y, Pan L, Lv S, Han H, Wang G. The CLE gene family in Populus trichocarpa. Plant Signal Behav. 2016.
Araya T, von Wirén N, Takahashi H. CLE peptide signaling and nitrogen interactions in plant root development. Plant Mol Biol. 2016.
Szatmári-Tóth M, Kristóf E, Veréb Z, Akhtar S, Facskó A, Fésüs L, Kauppinen A, Kaarniranta K, Petrovski G. Clearance of autophagy-associated dying retinal pigment epithelial cells - a possible source for inflammation in age-related macular degeneration. Cell Death Dis. 2016;7(9):e2367.
Ruiz-Delgado GJ, Peña AALeón, Gómez-de-León A, Ruiz-Argüelles GJ. Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report. Hematology. 2016.
Hutten TJA, Thordardottir S, Fredrix H, Janssen L, Woestenenk R, Tel J, Joosten B, Cambi A, Heemskerk MHM, Franssen GM, et al. CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses. J Immunol. 2016.
Song Y, Song NX, Liu XM, Kong FS, Fang Y, Xie LN, Yu Z, Song XC, Zhou F. [Clinical analysis of allogeneic hematopoietic stem cell transplantation for treatment of 71 cases of severe aplastic anemia]. Zhonghua Xue Ye Xue Za Zhi. 2016;37(2):151-153.
Cai WZ, Liu B, Xu Y, Chen SN, Sun AN, He J, Shen HJ, Wu DP. [Clinical and laboratory characteristics and treatment option for Philadelphia positive acute lymphoblastic leukemia patients with ABL kinase domain mutations]. Zhonghua Xue Ye Xue Za Zhi. 2016;37(2):105-109.
Shibazaki T, Hirabayashi K, Saito S, Shigemura T, Nakazawa Y, Sakashita K, Takagi M, Shiohara M, Adachi K, Nanba E, et al. Clinical and laboratory outcomes after umbilical cord blood transplantation in a patient with mucolipidosis II alpha/beta. Am J Med Genet A. 2016.
Shimoji M, Shimizu S, Sato K, Suda K, Kobayashi Y, Tomizawa K, Takemoto T, Mitsudomi T. Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1). Lung Cancer. 2016;98:69-75.
Xin Z, Lin G, Lei H, Lue TF, Guo Y. Clinical applications of low-intensity pulsed ultrasound and its potential role in urology. Transl Androl Urol. 2016;5(2):255-266.
Qin HL, Zhu XH, Zhang B, Zhou L, Wang WY. Clinical Evaluation of Human Umbilical Cord Mesenchymal Stem Cell Transplantation After Angioplasty for Diabetic Foot. Exp Clin Endocrinol Diabetes. 2016.
El-Mallawany NKim, Kamiyango W, Slone JS, Villiera J, Kovarik CL, Cox CM, Dittmer DP, Ahmed S, Schutze GE, Scheurer ME, et al. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016;11(4):e0153335.
Maciejka-Kemblowska L, Chaber R, Wrobel G, Maldyk J, Kozlowska M, Kulej D, Kazanowska B, Bubala H, Dembowska-Baginska B, Karolczyk G, et al. Clinical features and treatment outcomes of peripheral T-cell lymphoma in children. A current data report from Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG). Adv Med Sci. 2016;61(2):311-316.
Méndez-Echevarría A, Del Rosal T, Pérez-Costa E, Rodríguez-Pena R, Zarauza A, Ferreira-Cerdán A, Bravo M, Mellado MJosé, López-Granados E. Clinical Features Before Hematopoietic Stem Cell Transplantation or Enzyme Replacement Therapy of Children with Combined Immunodeficiency. Pediatr Infect Dis J. 2016.
Li Q, Zhong Z, Zeng C, Meng L, Li C, Luo Y, Wang H, Li W, Wang J, Cheng F, et al. A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors. Oncotarget. 2016.
Chu HY, Chin J, Pollard J, Zerr DM, Englund JA. Clinical Outcomes in Outpatient Respiratory Syncytial Virus Infection in Immunocompromised Children. Influenza Other Respir Viruses. 2016.
Sato K, Suda K, Shimizu S, Sakai K, Mizuuchi H, Tomizawa K, Takemoto T, Nishio K, Mitsudomi T. Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression. PLoS One. 2016;11(4):e0154186.
Boudou-Rouquette P, Tlemsani C, Blanchet B, Huillard O, Jouinot A, Arrondeau J, Thomas-Schoemann A, Vidal M, Alexandre J, Goldwasser F. Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review. Expert Opin Drug Metab Toxicol. 2016:1-12.
Huang X-H, Liu Z-H. The Clinical Presentation and Management of Systemic Light-Chain Amyloidosis in China. Kidney Dis (Basel). 2016;2(1):1-9.
Ceppi F, Stephens D, Hollander BS den, Krueger J, Whitlock J, Sung L, Hitzler J. Clinical presentation and risk factors of serious infections in children with Down syndrome treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2016.
Petruskevicius I, Ludvigsen M, Hjortebjerg R, Sørensen BS, Kamper P, Vase M, Oestgaard LG, Nielsen B, Honoré B, Bjerre M, et al. Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation. Bone Marrow Transplant. 2016.
Bao XB, Zhu Q, Qiu HY, Chen F, Xue SL, Ma X, Sun AN, Wu DP. [Clinical risks analysis of EBV infection in patients with allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2016;37(2):138-143.